This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

HPV

  1. Imagine you need treatment for cervical precancer.
    Published: November 2019
    Type: Article
  2. Global national HPV vaccine introduction maps.
    Published: November 2019
    Type: Resource Page
  3. This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.
    Published: September 2019
    Type: Resource Page
  4. Vaccines are one of the most effective global public health interventions ever.
    Published: April 2019
    Type: Article
  5. When more vaccine manufacturers are able to enter the market, supply increases while cost decreases. PATH supports emerging market vaccine manufacturers to do just that, improving access to lifesaving vaccines.
    Published: March 2019
    Type: Article
  6. The United States has a long history of leadership in global immunization. This educational fact sheet created by PATH and several advocacy partners highlights US government efforts in global immunization, including support for Gavi, the Vaccine Alliance; UNICEF; and the World Health Organization, as well as immunization activities carried out by the US Agency for International Development, US Department of Defense, and various agencies within the Department of Health and Human Services.
    Published: March 2019
    Type: Resource Page
  7. A synthesis of the white paper on current, published evidence relevant to single-dose HPV vaccination. This includes immunogenicity, efficacy and effectiveness; identification of gaps in the evidence; and forthcoming evidence.
    Published: September 2018
    Type: Resource Page
  8. This brief summarizes a comprehensive review and assessment of current, published evidence for a single-dose HPV vaccination schedule. The review was undertaken by researchers in the Single-Dose HPV Vaccine Evaluation Consortium.
    Published: September 2018
    Type: Resource Page
  9. There is broad recognition of the growing and inequitable burden of cervical cancer in low-resource countries, and uptake of new screening and treatment alternatives for adult women and human papillomavirus (HPV) vaccines for young adolescent girls is on the rise. For the first time in history the elimination of the disease is within reach, and on May 19, 2018, WHO Director-General, Dr. Tedros Adhanom Ghebreyesus made a global call for action on cervical cancer elimination. This fact sheet summarizes PATH's current work and future priorities.
    Published: July 2018
    Type: Resource Page
  10. The Single-Dose HPV Vaccine Evaluation Consortium encompasses nine leading independent research institutions working together to collate and synthesize existing evidence and evaluate new data on the potential for single-dose HPV vaccination.
    Published: July 2018
    Type: Resource Page
Load more